UK Markets close in 3 hrs 4 mins

West Pharmaceutical Services, Inc. (WST)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
339.36-2.34 (-0.68%)
At close: 04:03PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.13
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3475.35
52-week low 3275.89
50-day moving average 3309.70
200-day moving average 3372.63

Share statistics

Avg vol (3-month) 3425.59k
Avg vol (10-day) 3413.16k
Shares outstanding 574.08M
Implied shares outstanding 6N/A
Float 873.61M
% held by insiders 10.62%
% held by institutions 197.99%
Shares short (14 Jul 2022) 4960.79k
Short ratio (14 Jul 2022) 42.09
Short % of float (14 Jul 2022) 41.69%
Short % of shares outstanding (14 Jul 2022) 41.30%
Shares short (prior month 14 Jun 2022) 4761k

Dividends & splits

Forward annual dividend rate 40.72
Forward annual dividend yield 40.21%
Trailing annual dividend rate 30.68
Trailing annual dividend yield 30.20%
5-year average dividend yield 40.37
Payout ratio 47.92%
Dividend date 302 Aug 2022
Ex-dividend date 418 Jul 2022
Last split factor 22:1
Last split date 326 Sept 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022

Profitability

Profit margin 23.41%
Operating margin (ttm)26.94%

Management effectiveness

Return on assets (ttm)15.67%
Return on equity (ttm)30.76%

Income statement

Revenue (ttm)2.93B
Revenue per share (ttm)39.26
Quarterly revenue growth (yoy)6.60%
Gross profit (ttm)1.18B
EBITDA 913M
Net income avi to common (ttm)685.6M
Diluted EPS (ttm)8.06
Quarterly earnings growth (yoy)0.60%

Balance sheet

Total cash (mrq)718.5M
Total cash per share (mrq)9.7
Total debt (mrq)332.5M
Total debt/equity (mrq)13.72
Current ratio (mrq)3.13
Book value per share (mrq)29.72

Cash flow statement

Operating cash flow (ttm)675.2M
Levered free cash flow (ttm)268.31M